相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antisense Oligonucleotides As Potential Therapeutics for Type 2 Diabetes
Suxiang Chen et al.
NUCLEIC ACID THERAPEUTICS (2021)
Peptide-Drug Conjugates with Different Linkers for Cancer Therapy
Mona Alas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Dimerization/oligomerization of the extracellular domain of the GLP-1 receptor and the negative cooperativity in its ligand binding revealed by the improved NanoBiT
Xiaohan Song et al.
FASEB JOURNAL (2020)
NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression
Stefanie Wittrisch et al.
MOLECULAR METABOLISM (2020)
Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells
Zijian Fang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased Agonists
Zijian Fang et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Targeted pharmacological therapy restores β-cell function for diabetes remission
Stephan Sachs et al.
NATURE METABOLISM (2020)
Selective tissue targeting of synthetic nucleic acid drugs
Punit P. Seth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates
Michael E. Ostergaard et al.
NUCLEIC ACIDS RESEARCH (2019)
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2019)
Glucagon-like peptide 1 (GLP-1)
T. D. Mueller et al.
MOLECULAR METABOLISM (2019)
Endothelin-converting enzyme-1 regulates glucagon-like peptide-1 receptor signalling and resensitisation
Jing Lu et al.
BIOCHEMICAL JOURNAL (2019)
Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications
Sebastien Benizri et al.
BIOCONJUGATE CHEMISTRY (2019)
The MemProtMD database: a resource for membrane-embedded protein structures and their lipid interactions
Thomas D. Newport et al.
NUCLEIC ACIDS RESEARCH (2019)
Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay
Hans J. Gaus et al.
NUCLEIC ACIDS RESEARCH (2019)
Covalent Modification of Biomolecules through Maleimide-Based Labeling Strategies
Kevin Renault et al.
BIOCONJUGATE CHEMISTRY (2018)
Targeting GLP-1 receptor trafficking to improve agonist efficacy
Ben Jones et al.
NATURE COMMUNICATIONS (2018)
Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver
Colton M. Miller et al.
NUCLEIC ACID THERAPEUTICS (2018)
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Do Not
R. L. Juliano
NUCLEIC ACID THERAPEUTICS (2018)
Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex
Yi-Lynn Liang et al.
NATURE (2018)
Targeted delivery of antisense oligonucleotides to pancreatic β-cells
C. Ammala et al.
SCIENCE ADVANCES (2018)
Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism
Abhisek Mukherjee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
Yan Zhang et al.
NATURE (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin p114a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro
Joakim E. Swedberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
Chris de Graaf et al.
PHARMACOLOGICAL REVIEWS (2016)
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Richard S. Geary et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Efficient Synthesis and Biological Evaluation of 5′-GalNAc Conjugated Antisense Oligonucleotides
Michael E. Ostergaard et al.
BIOCONJUGATE CHEMISTRY (2015)
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
Jesper Lau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects
Hongkai Zhang et al.
NATURE COMMUNICATIONS (2015)
Functional Consequences of Glucagon-like Peptide-1 Receptor Cross-talk and Trafficking
Sarah Noerklit Roed et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications
Bikash Manandhar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
Sarah Noerklit Roed et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
Characterization of Target mRNA Reduction Through In Situ RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in Animals
Gene Hung et al.
NUCLEIC ACID THERAPEUTICS (2013)
The structure and function of the glucagon-like peptide-1 receptor and its ligands
Dan Donnelly
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Targeted estrogen delivery reverses the metabolic syndrome
Brian Finan et al.
NATURE MEDICINE (2012)
Regulation of GIP and GLP1 Receptor Cell Surface Expression by N-Glycosylation and Receptor Heteromerization
Gina M. Whitaker et al.
PLOS ONE (2012)
A Novel Human-Based Receptor Antagonist of Sustained Action Reveals Body Weight Control by Endogenous GLP-1
James T. Patterson et al.
ACS CHEMICAL BIOLOGY (2011)
ViennaRNA Package 2.0
Ronny Lorenz et al.
ALGORITHMS FOR MOLECULAR BIOLOGY (2011)
Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
Christina Rye Underwood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Synthesis and Biophysical Evaluation of 2′,4′-Constrained 2′O-Methoxyethyl and 2′4′-Constrained 2′O-Ethyl Nucleic Acid Analogues
Punit P. Seth et al.
JOURNAL OF ORGANIC CHEMISTRY (2010)
Allosteric Ligands of the Glucagon-Like Peptide 1 Receptor (GLP-1R) Differentially Modulate Endogenous and Exogenous Peptide Responses in a Pathway-Selective Manner: Implications for Drug Screening
Cassandra Koole et al.
MOLECULAR PHARMACOLOGY (2010)
Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain
Steffen Runge et al.
BIOCHEMISTRY (2007)
Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat) -: A new model for type 2 diabetes
AE Butler et al.
DIABETES (2004)
The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity
ME Doyle et al.
REGULATORY PEPTIDES (2003)
分享论文
